(Q34440962)

2 August 2017

1 reference

title

Review article: the management of paediatric nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

2 August 2017

0 references

1 reference

E B Mitchel

1

1 reference

2 August 2017

J E Lavine

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

29 September 2014

1 reference

Alimentary Pharmacology & Therapeutics

2 August 2017

published in

1 reference

2 August 2017

volume

40

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

1155-1170

1 reference

Prevalence of fatty liver in children and adolescents.

2 August 2017

cites work

1 reference

Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008

21 January 2018

1 reference

Medical therapy for nonalcoholic fatty liver disease in children and adolescents

21 January 2018

1 reference

Advances in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

21 January 2018

1 reference

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets

21 January 2018

1 reference

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions

21 January 2018

1 reference

Dietary treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis

21 January 2018

1 reference

Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults

21 January 2018

1 reference

Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study

21 January 2018

1 reference

Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children

21 January 2018

1 reference

Persistent hyperaminotransferasemia resolving after weight reduction in obese children

21 January 2018

1 reference

NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice

21 January 2018

1 reference

Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children

21 January 2018

1 reference

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

21 January 2018

1 reference

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

21 January 2018

1 reference

Exercise protects against high-fat diet-induced hypothalamic inflammation.

21 January 2018

1 reference

Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins

21 January 2018

1 reference

Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients.

21 January 2018

1 reference

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

21 January 2018

1 reference

AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiolo

21 January 2018

1 reference

Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes.

21 January 2018

1 reference

Childhood obesity for pediatric gastroenterologists.

21 January 2018

1 reference

Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD

21 January 2018

1 reference

Dietary fat content modifies liver fat in overweight nondiabetic subjects.

21 January 2018

1 reference

Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction

21 January 2018

1 reference

Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects

21 January 2018

1 reference

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

21 January 2018

1 reference

The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study

21 January 2018

1 reference

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

21 January 2018

1 reference

Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol

21 January 2018

1 reference

Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis.

21 January 2018

1 reference

Parent- and adolescent-reported barriers to participation in an adolescent overweight and obesity intervention.

21 January 2018

1 reference

Parent reasons for nonreturn to a pediatric weight management program

21 January 2018

1 reference

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

21 January 2018

1 reference

Nonalcoholic fatty liver disease and bariatric surgery in adolescents

21 January 2018

1 reference

Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement

21 January 2018

1 reference

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery

21 January 2018

1 reference

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

Best practice guidelines in pediatric/adolescent weight loss surgery.

21 January 2018

1 reference

Laparoscopic adjustable gastric banding for morbidly obese adolescents affects android fat loss, resolution of comorbidities, and improved metabolic status

21 January 2018

1 reference

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

21 January 2018

1 reference

A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.

21 January 2018

1 reference

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial

21 January 2018

1 reference

Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial

21 January 2018

1 reference

Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis

21 January 2018

1 reference

The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease

21 January 2018

1 reference

Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease

21 January 2018

1 reference

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

21 January 2018

1 reference

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes

21 January 2018

1 reference

OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease

21 January 2018

1 reference

Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects

21 January 2018

1 reference

Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents.

21 January 2018

1 reference

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

Twice-daily cysteamine bitartrate therapy for children with cystinosis

21 January 2018

1 reference

Regulation of glutathione synthesis

21 January 2018

1 reference

Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease.

21 January 2018

1 reference

The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects

21 January 2018

1 reference

Pediatric non-alcoholic fatty liver disease: an increasing public health issue.

21 January 2018

1 reference

High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics

21 January 2018

1 reference

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat.

21 January 2018

1 reference

Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease

21 January 2018

1 reference

The role of the gut microbiota in nonalcoholic fatty liver disease

21 January 2018

1 reference

Probiotics: a potential target for the prevention and treatment of steatohepatitis.

21 January 2018

1 reference

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells

21 January 2018

1 reference

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

21 January 2018

1 reference

Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury

21 January 2018

1 reference

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

21 January 2018

1 reference

Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.

21 January 2018

1 reference

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice

21 January 2018

1 reference

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.

21 January 2018

1 reference

Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.

21 January 2018

1 reference

Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia

21 January 2018

1 reference

Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study.

21 January 2018

1 reference

Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease

21 January 2018

1 reference

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis

21 January 2018

1 reference

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

21 January 2018

1 reference

Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children.

21 January 2018

1 reference

Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis.

21 January 2018

1 reference

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial

21 January 2018

1 reference

Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target

21 January 2018

1 reference

Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis

21 January 2018

1 reference

Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease

21 January 2018

1 reference

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trials

21 January 2018

1 reference

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

21 January 2018

1 reference

A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis.

21 January 2018

1 reference

Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease

21 January 2018

1 reference

Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease

21 January 2018

1 reference

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

21 January 2018

1 reference

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

21 January 2018

1 reference

Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD.

21 January 2018

1 reference

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment

21 January 2018

1 reference

Noninvasive measures of liver fibrosis

21 January 2018

1 reference

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

21 January 2018

1 reference

Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy

21 January 2018

1 reference

Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience

21 January 2018

1 reference

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

21 January 2018

1 reference

The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan

21 January 2018

1 reference

Assessment of hepatic fibrosis with magnetic resonance elastography

21 January 2018

1 reference

Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

21 January 2018

1 reference

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography

21 January 2018

1 reference

Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

21 January 2018

1 reference

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents

21 January 2018

1 reference

A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease

21 January 2018

1 reference

The Western Dietary Pattern Is Prospectively Associated With Nonalcoholic Fatty Liver Disease in Adolescence

21 January 2018

1 reference

Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E

21 January 2018

1 reference

How different is the dietary pattern in non-alcoholic steatohepatitis patients?

21 January 2018

1 reference

Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

21 January 2018

1 reference

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12972

1 reference

2 August 2017

1 reference